Zions Bancorporation, National Association’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$566K Buy
9,829
+479
+5% +$27.5K 0.03% 239
2026
Q1
$567K Buy
9,350
+2,524
+37% +$147K 0.04% 247
2025
Q4
$368K Buy
6,826
+1,219
+22% +$58.6K 0.02% 342
2025
Q3
$253K Sell
5,607
-880
-14% -$41.1K 0.01% 352
2025
Q2
$300K Sell
6,487
-164,245
-96% -$8.06M 0.02% 305
2025
Q1
$10.4M Buy
+170,732
New +$9.95M 0.66% 26

Other funds holding BMY

Zions Bancorporation, National Association's BMY Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2026, buying an estimated $27.5K and bringing the position to 9,829 shares worth $566K. The position accounts for 0.03% of the portfolio, ranked #239.

Zions Bancorporation, National Association first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.4M in Q1 2025. 1,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Zions Bancorporation, National Association held 9,829 shares of Bristol-Myers Squibb worth $566K as of Q2 2026.
  • Zions Bancorporation, National Association bought 479 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.5K.
  • Bristol-Myers Squibb made up 0.03% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #239 holding.
  • Zions Bancorporation, National Association first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Bristol-Myers Squibb position peaked at $10.4M in Q1 2025.
  • 1,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.